Member Info for Borsaci06

i3 Energy plc

("i3" or the "Company")

Result of General Meeting

i3 Energy plc is pleased to announce that, following the conclusion of its general meeting held earlier today, the resolution was duly passed to approve the acquisition of all the issued and outstanding common stock of Toscana Energy Income Corporation on the terms and subject to the conditions set out in the Company's admission document dated 13 October 2020.

TheAbbott (0)
User Actions
12 minutes ago
18 Reads
Post# 31788142
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Share volume
Who's going to call the vote then, I recon a clear yes, vote passed.

https://stockhouse.com/companies/bullboard/t.tei/toscana-energy-income-corporation?postid=31788142

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Share volume
posted October 27, 2020 11:08 am by TheAbbott

Who's going to call the vote then, I recon a clear yes, vote passed. rate and reply
https://stockhouse.com/companies/bullboard/t.tei/toscana-energy-income-corporation?postid=31788142

21 October at 18:35 ·
Luke O'Neill's COVID-19 Update
The danger of long-haul flights, fighting Yellow Fever, and a new therapy for COVID-19.

https://www.facebook.com/watch/?extid=0&v=685731968989491

ICMR recommends dropping Interferon, adding cancer drug Acalabrutinib to WHO Solidarity trial

https://theprint.in/health/icmr-recommends-dropping-interferon-adding-cancer-drug-acalabrutinib-to-who-solidarity-trial/529479/

well said

directors know that SP tanks when they sell

Nicola Bidoli
@BidoliNicola
Why do we need to change the antigenetics of a virus, PhD Baric, @Baric_Lab?
What is the purpose? Perhaps you are driven by a perverse will, like Dr. Frankenstein, to encourage yo to block the antiviral action of a future vaccine.

"The one more function we gave the virus is the changed its antigenicity
that is, any future vaccine, or antibody, would not have protected people from its infectious action"... R.Baric.

https://twitter.com/BidoliNicola/status/1318538314463457280

https://translate.google.com/translate?hl=en&sl=auto&tl=en&u=https%3A%2F%2Fwww.huffingtonpost.it%2Famp%2Fentry%2Fe-possibile-creare-un-virus-in-laboratorio-senza-lasciare-traccia-la-risposta-dellesperto_it_5f5f3993c5b62874bc1f7339%2F

Davethedumplin

yes we do have patent for Interferon Lambda for which the reason it is posted

** Viral clearance highly correlated with baseline viral loads
** All Lambda-treated patients were below the infectivity threshold by Day 7
https://ir.eigerbio.com/news-releases/news-release-details/eiger-biopharmaceuticals-announces-positive-results-investigator

https://naturemicrobiologycommunity.nature.com/posts/two-distinct-immunopathological-profiles-in-autopsy-lungs-of-covid-19

Oct 11, 2020
Pathologists.............................our findings have several implications..................
"" the correlation of low viral counts and an activated CD8+ T cell signature in lungs implies that establishing CD8+ immunity should be considered in vaccination efforts ""

Emergex CD8+T Cell programing

so there is a more than enough room for MTX110 Medulloblastoma
https://clinicaltrials.gov/ct2/show/NCT04315064

2020 Oct 12
Functional precision medicine identifies new therapeutic candidates for medulloblastoma
https://pubmed.ncbi.nlm.nih.gov/33046443/

https://www.covidtrialathome.com/

Yet another,
Midatech MTX110 may help him,

Fabulous Family, I’ve been reminded to live life to the full, because of some brain tumour / cancer thing. family, bikes, wine and craft ale seem a good start

https://twitter.com/liamdbergin

Again,
Midatech MTX110 may help her

Charlotte is a beautiful, strong, smart 7-year-old

https://www.readingunitedac.com/charlottestrong

Midatech MTX110 may help him

Bam had been fighting DIPG

https://www.gofundme.com/f/help-bam-fight-dipg-a-rare-brain-cancer?utm_source=twitter&utm_medium=social&utm_campaign=m_pd+share-sheet

Peter Suzman
@Biomaven
SARS-COV-2 uses three independent methods to inhibit interferon response, using proteins it makes very early in its cycle, even before making the dsRNA that would set off immune response.

https://career.caltech.edu/news/how-sars-cov-2-disables-human-cellular-alarm-system

https://doi.org/10.1016/j.cell.2020.10.004
How SARS-CoV-2 Disables the Human Cellular Alarm System
New research determines the precise ways that the COVID-19 virus disrupts normal cellular function, rendering cells unable to call for help
career.caltech.edu
1:14 AM · Oct 11, 2020·Twitter Web App

good read with visuals

"" Dr. Puglisi suspects that Nsp1 stops our cells from making proteins of their own — especially the antiviral proteins that could destroy the virus. But that raises the question of how the virus gets its own proteins made

Noam Stern-Ginossar and her colleagues at the Weizmann Institute in Israel, for example, have found evidence that the virus makes proteins that scientists have yet to find ""

https://www.nytimes.com/interactive/2020/health/coronavirus-unveiled.html?searchResultPosition=4

Rassemblement National - Hauts de France
@rn_hdf

Marie-Christine Bourgeois : « Nous sommes bien sûr favorables à ce soutien. Nous soutenons aussi le projet de recherche sur l’interféron inhalé à Amiens qui passe en commission permanente et que nous vous demandons de soutenir depuis le mois d’avril ! » #directHDF #hautsdefrance

Translated from French by

Marie-Christine Bourgeois: “We are of course in favor of this support. We are also supporting the research project on inhaled interferon in Amiens, which is going into a standing committee and which we have been asking you to support since April! "#directHDF#hautsdefrance
Image
2:42 PM · Oct 13, 2020·Twitter Web App

old news but pre-IPO PHARMA NEWS posted today

Pre-IPO Pharma
@preipopharma
Emergex Vaccines Forms US Subsidiary (Emergex USA) by Acquisition of Laboratories, Technology and Assets of US-Based T Cell Specialist Biotech ImmProNano http://preipopharma.com/press-releases/Emergex-Vaccines-Forms-US-Subsidiary-Emergex-USA-by-Acquisition-of-Laboratories-Technology-and-Assets-of-USBased-T-Cell-Specialist-Biotech-ImmProNano
#preIPO #biotech #pharmaceuticals
Image
2:22 AM · Oct 13, 2020·preIPO Pharma

https://twitter.com/preipopharma/status/1315825183761072128

https://www.preipopharma.com/press-releases/Emergex-Vaccines-Forms-US-Subsidiary-Emergex-USA-by-Acquisition-of-Laboratories-Technology-and-Assets-of-USBased-T-Cell-Specialist-Biotech-ImmProNano